Clinical trial
COVID SAFE 2.0: COVID-19 Screening Program
NCT05216627 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- COVID SAFE 2.0: COVID-19 Screening Program
- Lead sponsor
- University of Pennsylvania
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 7, 2022
- Completion date
- July 1, 2022
- Enrollment
- 61 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.